Mission: Our mission at Bausch + Lomb is helping you see better to live better. The Bausch + Lomb Vision Care Strategic Pillars include accelerating portfolio growth, becoming a preferred customer partner, develop our people, and strengthen our partnerships with prescribers.
Bausch + Lomb, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX), is solely dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our mission is simple yet powerful: Helping you see better to live better.
The company is one of the best-known and most respected healthcare brands in the world, offering the widest and finest range of eye health products including contact lenses and lens care products, pharmaceuticals, intraocular lenses and other eye surgery products.
Our highest priority is the well-being of the people we serve. By listening to our customers and patients, by constantly honing our innovation edge, by executing with integrity and excellence, we strive to earn the trust of our partners and stakeholders.
Over the last 150 years, Bausch + Lomb has become a global hallmark for innovation and quality. Our talented and motivated colleagues work relentlessly to invent new materials, engineer new technologies, and ultimately bring new innovations to help people see better to live better.
We Market Three Broad Categories Of Products
Vision Care: Our contact lens offerings span the entire spectrum of wearing modalities and include such well-known brand names as PureVision, SofLens, Boston and Optima. Our lens care products include Biotrue and renu brand of chemical disinfectants for soft contact lenses as well as the Boston line of products for cleaning GP contact lenses.
Pharmaceuticals: Our products treat a wide range of eye conditions including glaucoma, eye allergies, conjunctivitis, dry eye and retinal diseases. We offer proprietary and generic medicines available by prescription, over-the-counter eye drops and other medications. Our line of proprietary Rx products includes the antibacterial eye drops Besivance, the steroid eye drops Lotemax, Alrex, and Zylet, and, Retisert and Vitrasert to treat retinal diseases. Outside the U.S., the non-selective beta blocker, Carteol; Minims, preservative-free, single-dose drops; and Liposic ointment for dry eye. Leading OTC products include the Ocuvite and PreserVision brands of ocular vitamins, Soothe dry eye drops, and Alaway allergy drops.
Cataract and Vitreoretinal Surgery: We offer a full suite of products including intraocular lenses and delivery systems featuring the Crystalens, SofPort and Akreos brands of IOLs, the Stellaris and Millennium lines of phacoemulsification equipment, and other surgical instruments and devices, including the Storz line of instruments.
At a Glance
The company began in 1853 in Rochester, New York, as a small optical shop that grew to become a multi-billion dollar corporation with approximately 12,000 employees worldwide, and with products available in more than 100 countries. In October 2007, Warburg Pincus led the acquisition of Bausch + Lomb, which had previously been a publicly traded NYSE company. In August of 2013, Bausch + Lomb was acquired by Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and became the eye care division of Valeant.
The Bausch + Lomb Story
John Jacob Bausch and Henry LombOne of the oldest continually operating companies in the US today, Bausch + Lomb traces its roots to 1853, when John Jacob Bausch, a German immigrant, set up a tiny optical goods shop in Rochester, New York. When he needed more money to keep the business going, Bausch borrowed $60 from his good friend, Henry Lomb. Bausch promised that if the business grew, Lomb would be made a full partner. The business did grow and the partnership was formed.
In the early years, Bausch + Lomb manufactured revolutionary rubber eyeglass frames as well as a variety of optical products that required a high degree of manufacturing precision. By 1903, the firm had been issued patents for microscopes, binoculars, and even a camera shutter based on the eye’s reaction to light...
A History of Innovation
In the 1900’s, Bausch + Lomb continued to demonstrate its place at the forefront of technological innovation for optical products. Bausch + Lomb produced the first optical quality glass made in America, developed ground-breaking sunglasses for the military in World War I, and created the lenses used on the cameras that took the first satellite pictures of the moon. In 1971, Bausch + Lomb introduced the first soft contact lenses and is still the largest global provider of eye care products.
Although products and times have changed, Bausch + Lomb still adheres to the legacy of dedication to innovation, quality, and craftsmanship established by John Jacob Bausch and Henry Lomb. In August 2013, Bausch + Lomb became the eye care division of Valeant Pharmaceuticals International, Inc.
Bausch + Lomb believes in equal opportunity for all, without regard to race, religion, color, national origin, citizenship, sex, veteran's status, age, marital status, sexual preference, disability or any other protected personal characteristic. We will make reasonable accommodations for known physical or mental limitations of otherwise qualified employees and applicants with disabilities unless the accommodation would impose an undue hardship on the operation of our business. To request an accommodation during the process please contact 908-927-1946.
I worked at Bausch + Lomb full-time (More than 3 years)
Good facility, recent expansion and older parts of the plant revamped.
Career progression, but overall a good place to work.
I applied through a staffing agency. The process took a week. I interviewed at Bausch + Lomb (Saint Louis, MO) in April 2019.
There was a panel interview, but not the old boardroom stuffy kind. I spoke to 6 people individually, in their private offices. 3 were my soon-to-be superiors and 3 were peers. I never felt like I was being grilled, but rather conversing with them. The biggest emphasis was them figuring out if I would mesh well with the group. There were a few times my resume was referenced but the preferred that I verbally dictate my skills and abilities versus them reading the paper.